Clinical question: What is the best treatment for bacterial conjunctivitis? Results: Topical antibiotics expedite recovery from bacterial conjunctivitis. The choice of antibiotic usually does not affect outcome. Implementation: Recognition of key distinguishing features of bacterial conjunctivitis • Pitfalls that can be recognized in the history and physical examination • Choice of antibiotic • When to refer for specialist treatment. Keywords: bacterial conjunctivitis, topical antibiotics
the current evidence suggests that the choice of topical antibiotics and the treatment regimen do not significantly affect the rate of recovery The evidence Table 1 randomized controlled trials comparing antibiotics with placebo
Author
Number of patients randomized
Interventions

Outcome measures Results
Abelson et al 4 
279
One group received azithromycin One group received "vehicle"
Clinical resolution and bacterial eradication
Higher rate of microbial and clinical cure with antibiotic. Everitt et al 5 
307
Two groups received chloramphenicol One group received placebo Symptomatic relief Antibiotic decreased the duration of symptoms. Hwang et al 6 
249
One group received levofloxacin One group received placebo
Clinical resolution and bacterial eradication
Higher rate of microbial and clinical cure with antibiotic. Karpecki et al 7 
269
One group received besifloxacin One group received "vehicle"
Clinical resolution and bacterial eradication 2 which includes a meta-analysis, concluded that "acute bacterial conjunctivitis is frequently a self-limiting condition, but the use of antibiotics is associated with significantly improved rates of clinical and microbiological remission". The systematic review by Clinical Evidence 3 concludes that topical antibiotics are "beneficial" in people with culture-positive nongonococcal bacterial conjunctivitis and "likely to be beneficial" when used empirically in people with suspected bacterial conjunctivitis within 1-2 days if symptoms do not resolve on their own. Oral antibiotics, ocular decongestants, warm compresses, and saline were found to be of "unknown effectiveness".
Most randomized controlled trials (see Table 1 ) showed that topical antibiotics accelerate bacterial eradication and help resolve the signs and symptoms of bacterial conjunctivitis. However, in two trials, 4, 5 clinical recovery at seven days after presentation was found to be unaffected by the use of antibiotics, even though one of the two trials 4 still found an improvement in microbial cure rate with antibiotics.
Which antibiotics are best for accelerating resolution of bacterial conjunctivitis? Table 2 lists the antibiotics studied, along with their microbial coverage, mechanism of action, and availability. The systematic review 3 concluded that "there is no clear best choice for topical antibiotics -local microbiological resistance patterns, cost, dosing regimens, and other patient factors (such as allergies and compliance) are important considerations in addition to efficacy". Results from randomized controlled trials (Table 3) A few randomized controlled trials (Table 4) have focused on the effect of the treatment regimen, such as dosing, frequency, length of treatment, and route of administration, on efficacy rates. None have found a significant change in cure rate in association with the treatment regimen used.
Conclusions
Bacterial conjunctivitis often resolves on its own, but the current evidence suggests that topical antibiotics help accelerate recovery from this self-limiting disease. Topical antibiotics used for treatment of bacterial conjunctivitis have similar efficacy rates. The treatment regimen does not affect recovery from bacterial conjunctivitis. Patients may prefer a simpler regimen.
there may be itching, chemosis, or conjunctival papillae • Ask about contact lens wear • Assess for corneal involvement and intraocular involvement • Conjunctival swabs can be done for Gram stain, culture, and sensitivity to clarify diagnosis, particularly in more severe or refractory cases • Moderate to severe eye pain, photophobia, or change in visual acuity should raise suspicion for more serious causes.
Treatment
• Uncomplicated cases can be treated with a topical antibiotic such as tobramycin, trimethoprim/polymyxin B, a fluoroquinolone or chloramphenicol four times daily for 5-7 days to accelerate recovery • Patients should be seen every 2-3 days until signs and symptoms are resolved
Potential pitfalls
• Contact lens wearers are predisposed to Gram-negative infections, carrying a higher risk of complications, such as bacterial keratitis. Pseudomonas and Acanthamoeba infections in contact lens wearers can lead to serious, sight-threatening complications if not recognized and treated appropriately. The contact lens storage case may be the nidus of the infection.
• If there is an associated keratitis or anterior uveitis, referral to a specialist may be recommended • Beware of combination topical antibiotic agents that contain steroids. These should be used with extreme caution and monitored by a specialist.
Management
Bacterial conjunctivitis can be managed by nonspecialists.
Assessment
• Redness, foreign body sensation and purulent/ mucopurulent discharge are common complaints;
• Failure to respond to topical antibiotics may warrant referral to a specialist.
indications for specialist referral 
